← Back to overview

RMD ResMed Inc.

Health Care Equipment · $195.27 +1.76%
Price Alert:
Price & Volume
RSI (14)
MACD (12, 26, 9)

Compare

Shows % change over the period so different-priced stocks can be compared fairly.

Technical Indicators

RSI (14)
49.7
Relative Strength Index (RSI): measures how fast and how much the price has moved recently, on a 0-100 scale. Above 70 is often called "overbought" (may be due for a pause or pullback); below 30 is "oversold" (may be due for a bounce). It is not a guarantee either way.
SMA 20 / 50 / 200
196.09 / 193.73 / —
Moving Averages (SMA): the average closing price over the last N days, smoothing out day-to-day noise. When price trades above its moving averages, and shorter averages are above longer ones, it is generally read as a healthier trend.
MACD / Signal
0.40 / 0.63
MACD: compares two moving averages (12-day and 26-day) to gauge momentum. When the MACD line crosses above its signal line, momentum is turning up; crossing below suggests momentum turning down.

Fundamentals

P/E
18.8
Price-to-Earnings ratio: how many dollars investors pay for $1 of the company's annual profit. Higher usually means the market expects faster growth (or the stock is expensive); lower can mean it's cheap — or that growth is expected to slow.
Market Cap
28.33B
Market Capitalization: the total value of all the company's shares — share price × number of shares. A rough measure of company size.
Div Yield
1.23%
Dividend Yield: the annual cash dividend paid to shareholders, as a percentage of the current share price.
52-Week Range
180.27 – 293.81
52-Week Range: the lowest and highest price the stock has traded at over the last year. Where the price sits in this range hints at recent strength or weakness.

Trend Analysis

ResMed Inc. is trading at $195.27, +1.76% versus the previous close. The price is near its 52-week low — the bottom of its recent trading range.
RSI is in a neutral range — no strong overbought/oversold signal.
MACD is below its signal line — momentum currently leans negative.
Combine this reading with the fundamentals below before forming a view — no single indicator is a guarantee of what happens next.

Latest News

BofA Adjusts Price Target on ResMed to $320 From $310
MT Newswires · 2026-07-24 12:47
3 Cash-Heavy Stocks to Research Further
StockStory · 2026-07-23 07:24
ResMed Earnings Growth Seen Strong as Ventilator Issue Clouds FY27, UBS Says
MT Newswires · 2026-07-21 17:05
RBC Downgrades ResMed to Sector Perform From Outperform, Cuts Price Target to $234 From $276
MT Newswires · 2026-07-17 10:22
SpaceX initiated, Lululemon downgraded: Wall Street's top analyst calls
The Fly · 2026-07-16 13:33
Mizuho Adjusts Price Target on ResMed to $220 From $235, Maintains Outperform Rating
MT Newswires · 2026-07-15 15:11
Baird Adjusts ResMed Price Target to $217 From $225, Maintains Neutral Rating
MT Newswires · 2026-07-14 12:09
2 Mid-Cap Stocks with Exciting Potential and 1 We Ignore
StockStory · 2026-07-14 10:23
Educational information only. Nothing here is investment advice — always do your own research and consider talking to a licensed financial advisor before buying or selling.
Data: Yahoo Finance, refreshed periodically and cached locally.